Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Fusion Pharmaceuticals Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −3 vs. Q3 2022
- Shares held
- 28.2M
- +1.65M (+6.2%) vs. Q3 2022
- Total value
- $88.9M
- +$8.63M (+10.7%) vs. Q3 2022
- New holders
- 3
- 5 more added
- Sold out
- 6
- 3 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 30 | $95 | 0.00% | +30 | New |
| Signaturefd, LLC | 300 | $945 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 335 | $1.05K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 850 | $3.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 875 | $3.01K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 8,253 | $26.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 12,510 | $39.4K | 0.00% | −15,984−56.1% | Reduced |
| Renaissance Technologies LLC | 23,500 | $74.0K | 0.00% | +6,700+39.9% | Added |
| Geode Capital Management, LLC | 25,136 | $79.0K | 0.00% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 43,394 | $136.7K | 0.01% | −58,537−57.4% | Reduced |
| Leonteq Securities AG | 53,000 | $166.9K | 0.01% | +53,000 | New |
| Sectoral Asset Management Inc | 57,297 | $180.5K | 0.03% | 00.0% | Unchanged |
| UBS Group AG | 62,676 | $197.4K | 0.00% | +7,772+14.2% | Added |
| Morgan Stanley | 107,948 | $340.0K | 0.00% | +31,271+40.8% | Added |
| Sofinnova Investments, Inc. | 117,099 | $368.9K | 0.02% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 260,448 | $820.4K | 0.44% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 328,868 | $1.04M | 0.00% | +18,800+6.1% | Added |
| Ra Capital Management, L.P. | 659,992 | $2.08M | 0.04% | 00.0% | Unchanged |
| 1832 Asset Management L.P. | 734,321 | $2.31M | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 750,000 | $2.36M | 0.14% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,984 | $4.92M | 2.14% | 00.0% | Unchanged |
| Braidwell LP | 2,000,000 | $6.30M | 0.21% | +2,000,000 | New |
| TPG GP A, LLC | 2,551,794 | $8.04M | 0.16% | 00.0% | Unchanged |
| FMR LLC | 2,692,054 | $8.48M | 0.00% | −354,759−11.6% | Reduced |
| Adams Street Partners LLC | 2,947,809 | $9.29M | 3.10% | 00.0% | Unchanged |
| Canada Pension Plan Investment Board | 3,116,966 | $9.82M | 0.02% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,224,100 | $10.2M | 0.03% | +50,000+1.6% | Added |
| OrbiMed Advisors LLC | 3,224,770 | $10.2M | 0.19% | 00.0% | Unchanged |
| Johnson & Johnson | 3,670,516 | $11.6M | 3.36% | 00.0% | Unchanged |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −50,390−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −17,286−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −14,600−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −2,900−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Paragon Wealth Strategies, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |